Keywords
University hospital
Health profile
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To describe the sociodemographic and clinical profile of patients with neuromuscular diseases treated at the Neuromuscular Disease Outpatient Clinic, located at the Child and Adolescent Health Care Unit (UASCA) of the a University Hospital in, Belém, Pará, Brazil. Methods: This is a quantitative-descriptive and retrospective study, in which the medical records of patients regularly enrolled in the service for a period of 2 years were analyzed, collecting sociodemographic and clinical data. Results: The research identified a predominance of males with a higher frequency of the clinical diagnosis of Duchenne Muscular Dystrophy, aged between 10-14 years, mostly from the Metropolitan Region of Belém, presenting some type of musculoskeletal deformity. Conclusion: Most patients had an average age of the first signs and symptoms of 2.8 years and an average age of diagnosis of 7.6 years, demonstrating a delay of approximately 05 years until obtaining a conclusive clinical diagnosis. Furthermore, most patients were diagnosed at the University Hospital itself.
References
BELHASAN DC e AKAABOUNE M. The role of the dystrophin glycoprotein complex on the neuromuscular system. Neuroscience Letters, 2020; 722: 134833.
BIRNKRANT DJ, et al. Diagnosis and management of Duchenne muscular dystrophy, part 3: primary care, emergency management, psychosocial care, and transitions of care across the lifespan. Lancet Neurol. 2018; 17(5): 445-455.
BLAKE e DEREK J. et al. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiological reviews, 2002; 82(2): 291–329.
CASTIGLIONI C et al. Enfermedades neuromusculares. Epidemiología y políticas de salud en Chile. Rev Médica Clínica Las Condes. 2018; 29(6): 594–8.
CORTÉS E, et al. Miastenia gravis de rápida instauración. Rev Clín Med Fam, 2021; 14(1): 28-30.
CRISAFULLI S, et al. Global epidemiology of Duchenne muscular dystrophy: An updated systematic review and meta-analysis. Orphanet J Rare Dis. 2020; 15(1).
DINIZ G. Pacientes portadores de doenças neuromusculares: um estudo longitudinal. [dissertação] [internet]. Belo Horizonte: Universidade Federal de Minas Gerais, 2010; 88.
DUAN e DONGSHENG et al. Duchenne muscular dystrophy. Nature Reviews Disease Primers, 2021; 7(1): 13.
EBSERH: 2020, empresa brasileira de serviços hospitalares. Bettina Ferro. Belém. Disponível em: https ://www.gov.br/ebserh/pt-br/hospitaisuniversitarios/regiao-norte/chu-ufpa/acesso-a-informacao/institucional/bettina-ferro. Acessado em 22 de setembro de 2023.
ENGEL JM, et al. Exploring Chronic Pain in Youths with Duchenne Muscular Dystrophy: A Model for Pediatric Neuromuscular Disease. Physical Medicine and Rehabilitation Clinics of North America, 2005; 16(4): 1113–1124.
GRIFFET J, et al. Lower extremity surgery in muscular dystrophy. Orthop Traumatol Surg Res. 2011; 97(6): 634-8.
IRIART JAB, et al. From the search for diagnosis to treatment uncertainties: Challenges of care for rare genetic diseases in Brazil. Cienc e Saude Coletiva. 2019; 24(10): 3637–50.
KENNEDY RA, et al. Walking and weakness in children: A narrative review of gait and functional ambulation in paediatric neuromuscular disease. J Foot Ankle Res. 2020; 13(1): 1–15.
MINISTÉRIO DA SAÚDE (BRASIL). Doenças raras: o que são, causas, tratamento, diagnóstico e prevenção. 2017. Disponível em: . Acessado em 10 de julho de 2023.
MONTENEGRO SC e SOLERVICENS PA. Perfil demográfico y clínico-funcional de pacientes con atrofia muscular espinal atendidos en el Instituto Teletón Santiago. Rehabil Integr. [internet]. 2020; 14(1): 30–9.
MOREIRA MCN e DO NASCIMENTO MAF, Horovitz DDG, Martins AJ, Pinto M. Quando ser raro se torna um valor: O ativismo político por direitos das pessoas com doenças raras no sistema Único de saúde. Cad Saude Publica. 2018; 34(1): 1–4.
PONTES JF, et al. Força muscular respiratória e perfil postural e nutricional em crianças com doenças neuromusculares. Fisioter em Mov. 2012; 25(2): 253–61.
REED UC. Doenças neuromusculares. J Pediatr (Rio J). 2002; 78: S89–103.
SKALSKY AJ e DALAL PB. Common Complications of Pediatric Neuromuscular Disorders. Phys Med Rehabil Clin N Am, 2015; 26(1): 21–8.
SOUZA ÍP et al. A qualitative approach to rare genetic diseases: An integrative review of the national and international literature. Cienc e Saude Coletiva. 2019; 24(10): 3683–700.
STREHLE EM. Long-term management of children with neuromuscular disorders. J Pediatr (Rio J). 2009; 85(5):3 79–84.